United States

Key Developments: MedAssets Inc (MDAS.OQ)

MDAS.OQ on NASDAQ Stock Exchange Global Select Market

27 Jan 2016
Change (% chg)

$0.01 (+0.03%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Latest Key Developments (Source: Significant Developments)

MedAssets Inc updates FY 2014 guidance - Conference Call
Tuesday, 13 Jan 2015 10:30am EST 

MedAssets Inc:Plans to end FY 2014 somewhere around a little over $715 million to $720 million range for revenue; $236 million is the midpoint of guidance for adjusted EBITDA; and then $1.36 earnings per share.FY 2014 revenue of $717 million, EBITDA of $237 million and EPS of $1.36 - Thomson Reuters I/B/E/S.  Full Article

MedAssets Inc COO Mike Nolte Promoted to President
Wednesday, 10 Dec 2014 10:15am EST 

MedAssets Inc:Says Mike Nolte, who currently serves as executive vice president and chief operating officer (COO), was promoted to president and COO and has been appointed to company's board, effective immediately.  Full Article

MedAssets Inc announces strategic partnership to deliver best-practice clinical value analysis programs
Monday, 1 Dec 2014 10:30am EST 

MedAssets Inc:Announces strategic partnership with Procured Health to deliver holistic approach to implementing best-practice clinical value analysis programs.Under terms of agreement, MedAssets will augment industry-leading clinical value analysis consulting and services with Procured Health's proprietary data intelligence and collaboration technology platform.The SaaS-based analytical tool and complementary purpose-built workflow solution provide hospital administrators and physicians unparalleled transparency into medical supply options and comparative safety and outcomes data.With improved market information and process oversight, hospitals are able to promote appropriate product utilization and optimize savings opportunities.  Full Article

MedAssets Inc raises FY 2014 guidance
Wednesday, 29 Oct 2014 04:06pm EDT 

MedAssets, Inc:Expects FY 2014 total net revenue of $715.0 - $721.0 mln.Expects FY 2014 Non-GAAP adjusted EBITDA of $234.0 - $238.0 mln.Expects FY 2014 GAAP EPS diluted of $0.49 - $0.53.Expects FY 2014 Non-GAAP adjusted EPS diluted of $1.34 - $1.38.FY 2014 revenue of $703.8 mln, EBITDA of $233.0 mln and EPS of $1.34 - Thomson Reuters I/B/E/S.  Full Article

Medassets completes acquisition of Sg2
Monday, 22 Sep 2014 04:05pm EDT 

Medassets Inc:Completes its previously announced acquisition of SG-2, LLC.Transaction value of $142 mln.  Full Article

LHP Hospital Group Inc expands relationship with MedAssets
Wednesday, 3 Sep 2014 08:30am EDT 

MedAssets Inc:Announced that LHP Hospital Group, Inc has elected to renew and expand its relationship with company.Says MedAssets will deploy wide array of its total cost management and clinical alignment solutions to streamline processes.Says MedAssets will Improve performance across 1,333-bed, six-hospital healthcare group, including Supply Chain Solutions, Procure-to-Pay Solutions, Cost Analytics and Operational Improvement Solution.New agreement builds upon existing relationship and deployment at LHP's hospitals of MedAssets Strategic Sourcing.  Full Article

MedAssets Inc signs definitive agreement to acquire Sg2
Wednesday, 13 Aug 2014 08:00am EDT 

MedAssets Inc:Signs definitive agreement to acquire privately held SG-2, LLC (Sg2).Says for about $142 mln.Under terms of agreement, MedAssets will acquire Sg2 for about $142 mln to be funded with cash on hand and borrowings under existing credit facility.Sg2 financial results and additional terms of the transaction were not disclosed.Transaction is subject to customary closing conditions and regulatory approvals, and is expected to be completed within 60 to 90 days.Deutsche Bank Securities Inc., is acting as the exclusive financial advisor to MedAssets in this transaction, and Willkie Farr & Gallagher LLP is acting as company's legal counsel.Marwood Group acted as market research advisor during due diligence for the transaction. Robert W. Baird is acting as financial advisor to Sg2 in the transaction, and Freeborn & Peters is acting as legal counsel.  Full Article

MedAssets Inc lowers FY 2014 guidance
Wednesday, 30 Jul 2014 04:04pm EDT 

MedAssets Inc:Expects FY 2014 total net revenue of $698.0 million - $710.0 million.Expects FY 2014 Non-GAAP adjusted EBITDA of $231.0 million - $239.0 million.Expects FY 2014 GAAP EPS diluted of $0.55 - $0.63.Expects FY 2014 Non-GAAP adjusted EPS diluted of $1.32 - $1.40.FY 2014 revenue of $705.8 million, EBITDA of $235.5 million and EPS of $1.37 - Thomson Reuters I/B/E/S.  Full Article

TRLPC: Microsemi tests fragile US leveraged loan market

NEW YORK, Dec 11 Chipmaker Microsemi is testing a volatile US leveraged loan market with a proposed US$2.425bn credit facility, weeks after the withdrawal of a US$5.5bn financing for software maker Veritas sent shockwaves through the market.

Search Stocks